翔宇医疗:期间费用提升,公司业绩短期承压
Xiangyu Medical(688626) 华安证券·2024-11-05 00:00
翔宇医疗( [Table_StockNameRptType] 688626) 公司点评 期间费用提升,公司业绩短期承压 | --- | --- | --- | |---------------------------------------------------------------------------------------------------------|----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资评级:买入(维 ...